David M Charytan1, Robert Foley2, Peter A McCullough3, John D Rogers4, Peter Zimetbaum5, Charles A Herzog2, James A Tumlin6. 1. Department of Medicine, Brigham & Women's Hospital, Boston, Massachusetts; Dcharytan@partners.org. 2. Department of Medicine, Hennepin County Medical Center, University of Minnesota, Minneapolis, Minnesota; 3. Department of Medicine, Baylor University Medical Center, Baylor Heart and Vascular Institute, Baylor Jack and Jane Hamilton Heart and Vascular Hospital, Dallas, Texas; Department of Medicine, Division of Cardiology, The Heart Hospital, Plano, Texas; 4. Department of Cardiology, Scripps Clinic, Torrey Pines, California; 5. Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts; and. 6. Department of Medicine, University of Tennessee, Chattanooga College of Medicine, Chattanooga, Tennessee.
Abstract
BACKGROUND: Dialysis patients have high rates of cardiovascular morbidity and mortality, but data on arrhythmia burden, arrhythmia type, arrhythmia triggers, and the identity of terminal arrhythmias have historically been limited by an inability to monitor heart rhythm for prolonged periods. OBJECTIVES: To investigate arrhythmia and its association with sudden death in dialysis-dependent ESRD, describe the potential for implantable devices to advance study of dialysis physiology, review the ethical implications of using implantable devices in clinical studies, and report on the protocol and baseline results of the Monitoring in Dialysis Study (MiD). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In this multicenter, interventional-observational, prospective cohort study, we placed implantable loop recorders in patients undergoing long-term hemodialysis. The proportion of patients experiencing clinically significant arrhythmias was the primary endpoint. For 6 months, we captured detailed data on the primary endpoint, symptomatic arrhythmias, other electrocardiographic variables, dialysis prescription, electrolytes, dialysis-related variables, and vital signs. We collected additional electrocardiographic data for up to 1 year. RESULTS: Overall, 66 patients underwent implantation in sites in the United States and India. Diabetes was present in 63.6% of patients, 12.1% were age ≥70 years, 69.7% were men, and 53.0% were black. Primary and secondary endpoint data are expected in 2016. CONCLUSIONS: Cardiac arrhythmia is an important contributor to cardiovascular morbidity and mortality in dialysis patients, but available technology has previously limited the ability to estimate its true burden and triggers and to define terminal rhythms in sudden death. Use of implantable technology in observational studies raises complex issues but may greatly expand understanding of dialysis physiology. The use of implantable loop recorders in MiD is among the first examples of such a trial, and the results are expected to provide novel insights into the nature of arrhythmia in hemodialysis patients.
BACKGROUND: Dialysis patients have high rates of cardiovascular morbidity and mortality, but data on arrhythmia burden, arrhythmia type, arrhythmia triggers, and the identity of terminal arrhythmias have historically been limited by an inability to monitor heart rhythm for prolonged periods. OBJECTIVES: To investigate arrhythmia and its association with sudden death in dialysis-dependent ESRD, describe the potential for implantable devices to advance study of dialysis physiology, review the ethical implications of using implantable devices in clinical studies, and report on the protocol and baseline results of the Monitoring in Dialysis Study (MiD). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In this multicenter, interventional-observational, prospective cohort study, we placed implantable loop recorders in patients undergoing long-term hemodialysis. The proportion of patients experiencing clinically significant arrhythmias was the primary endpoint. For 6 months, we captured detailed data on the primary endpoint, symptomatic arrhythmias, other electrocardiographic variables, dialysis prescription, electrolytes, dialysis-related variables, and vital signs. We collected additional electrocardiographic data for up to 1 year. RESULTS: Overall, 66 patients underwent implantation in sites in the United States and India. Diabetes was present in 63.6% of patients, 12.1% were age ≥70 years, 69.7% were men, and 53.0% were black. Primary and secondary endpoint data are expected in 2016. CONCLUSIONS:Cardiac arrhythmia is an important contributor to cardiovascular morbidity and mortality in dialysis patients, but available technology has previously limited the ability to estimate its true burden and triggers and to define terminal rhythms in sudden death. Use of implantable technology in observational studies raises complex issues but may greatly expand understanding of dialysis physiology. The use of implantable loop recorders in MiD is among the first examples of such a trial, and the results are expected to provide novel insights into the nature of arrhythmia in hemodialysis patients.
Authors: Patrick H Pun; Ruediger W Lehrich; Emily F Honeycutt; Charles A Herzog; John P Middleton Journal: Kidney Int Date: 2010-09-01 Impact factor: 10.612
Authors: Rulan S Parekh; Laura C Plantinga; W H Linda Kao; Lucy A Meoni; Bernard G Jaar; Nancy E Fink; Neil R Powe; Josef Coresh; Michael J Klag Journal: Kidney Int Date: 2008-09-03 Impact factor: 10.612
Authors: Christian Combe; Justin M Albert; Jennifer L Bragg-Gresham; Vittorio E Andreucci; Alex Disney; Shunichi Fukuhara; David A Goodkin; Brenda W Gillespie; Akira Saito; Michel Jadoul; Ronald L Pisoni Journal: Am J Kidney Dis Date: 2009-07-19 Impact factor: 8.860
Authors: Beste Ozben; Ahmet Toprak; Mehmet Koc; Mutlu Sumerkan; Azra M Tanrikulu; Nurdan Papila-Topal; Utku S Kefeli; Altug A Cincin; Oytun Baykan; Ali S Fak Journal: Nephron Clin Pract Date: 2009-04-24
Authors: L Paulis; J Matuskova; M Adamcova; V Pelouch; J Simko; K Krajcirovicova; A Potacova; I Hulin; P Janega; O Pechanova; F Simko Journal: Acta Physiol (Oxf) Date: 2008-04-16 Impact factor: 6.311
Authors: Eduardo Verde; Armando Pérez de Prado; Juan M López-Gómez; Borja Quiroga; Marian Goicoechea; Ana García-Prieto; Esther Torres; Javier Reque; José Luño Journal: Clin J Am Soc Nephrol Date: 2016-10-03 Impact factor: 8.237
Authors: Finnian R Mc Causland; Jim A Tumlin; Prabir Roy-Chaudhury; Bruce A Koplan; Alexandru I Costea; Vijay Kher; Don Williamson; Saurabh Pokhariyal; David M Charytan Journal: Clin J Am Soc Nephrol Date: 2020-05-07 Impact factor: 8.237
Authors: José Alberto Navarro-García; Angélica Rueda; Tatiana Romero-García; Jennifer Aceves-Ripoll; Elena Rodríguez-Sánchez; Laura González-Lafuente; Carlos Zaragoza; María Fernández-Velasco; Makoto Kuro-O; Luis M Ruilope; Gema Ruiz-Hurtado Journal: Br J Pharmacol Date: 2020-09-15 Impact factor: 8.739